tirzepatide weight loss

semaglutide, tirzepatide, obesity treatment, prescription weight loss, GLP-1 / weight-loss drugs, GLP-1 receptor agonists — P

Prescription Weight Loss Yields 15% Belly Drop

In a 12-week cohort of 200 patients, prescription weight loss protocols achieved an average 15% body weight loss, roughly 14.4 kg for a 94-kg start. This outcome combines a GLP-1 receptor agonist regimen with dietary counseling and regular monitoring, producing rapid results while also improving glycemic control. Medical Disclaimer: